Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI)

Historical Holders from Q3 2021 to Q3 2025

Symbol
TOI on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
87,441,936
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
33,859,364
Holdings value
$118,161,510
% of all portfolios
0.001%
Number of holders
106
Number of buys
65
Number of sells
-30
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SARIN RAVI YANG 4.7% $11,959,434 4,109,771 Ravi Sarin 26 Mar 2025

Institutional Holders of Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 33,859,364 $118,161,510 +$9,179,341 $3.49 106
2025 Q2 31,474,503 $64,523,702 +$31,211,552 $2.05 78
2025 Q1 16,901,932 $19,267,414 +$2,727,938 $1.14 42
2024 Q4 14,712,600 $4,608,917 -$2,191,797 $0.309 30
2024 Q3 20,589,694 $6,982,762 +$385,704 $0.3269 34
2024 Q2 18,701,866 $8,832,828 -$155,334 $0.46 38
2024 Q1 17,222,037 $27,535,675 -$2,492,260 $1.58 44
2023 Q4 18,436,129 $37,608,749 +$6,554,810 $2.04 44
2023 Q3 15,107,160 $21,169,015 +$1,157,191 $1.4 36
2023 Q2 13,916,345 $7,656,692 -$4,490,020 $0.5502 37
2023 Q1 21,905,923 $14,849,314 -$1,309,674 $0.6779 37
2022 Q4 23,473,725 $38,730,078 -$1,269,944 $1.65 37
2022 Q3 23,327,364 $108,006,612 +$6,672,135 $4.63 39
2022 Q2 21,874,386 $110,684,000 +$2,844,383 $5.06 33
2022 Q1 17,791,143 $126,852,000 -$752,294 $7.13 27
2021 Q4 21,118,138 $199,883,000 +$185,679,000 $9.75 21
2021 Q3 252,439 $2,504,000 +$2,504,000 $9.92 1